# Distinguishing Myo‐Inositol From Glycine in Brain MRS at 3T: A Pitfall Using Intermediate Echo Times

**Authors:** Seyma Alcicek, Georg Oeltzschner, Doris D. M. Lin, Peter B. Barker

PMC · DOI: 10.1111/jon.70107 · Journal of Neuroimaging · 2025-11-11

## TL;DR

This study shows that long echo times in brain MRS are better for distinguishing glycine from myo-inositol, avoiding misinterpretation of signals.

## Contribution

The paper quantitatively compares clinically available MRS sequences for differentiating glycine and myo-inositol using various echo times.

## Key findings

- Short and intermediate echo times produce ambiguous signals at 3.5 ppm that can be mistaken for glycine or myo-inositol.
- Long echo times eliminate the 3.5 ppm signal, aiding in accurate diagnosis of hypoxic-ischemic encephalopathy.
- Phantom and simulation data confirm that myo-inositol mimics glycine at intermediate echo times.

## Abstract

In in vivo magnetic resonance spectroscopy (MRS) of the brain, glycine (Gly) is traditionally separated from the overlapping signal of myo‐inositol (mI) through the use of intermediate (e.g., 130–140 ms) or long (270–280 ms) echo times (TE). However, no quantitative comparisons have been performed to date comparing the performance of clinically available MRS sequences to differentiate mI and Gly as a function of TE.

In vivo spectra recorded with two clinically available MRS pulse sequences (single voxel PRESS and semi‐LASER 2D‐MRSI) with short (35 ms), intermediate (135 ms), and long (280 ms) echo times in a neonate with clinically suspected nonketotic hyperglycinemia were compared to those recorded from phantoms, and spectral simulations.

In vivo spectra recorded at short and intermediate TE spectra showed signals at 3.5 ppm that could arise from either mI or Gly; however, long TE spectra showed an absence of signal in this spectral region, which was consistent with the final clinical diagnosis of hypoxic‐ischemic encephalopathy. Phantom data and spectral simulations demonstrated that at intermediate TE, mI has a “pseudo‐singlet” appearance that is very similar to that of Gly.

Long echo times are used to best discriminate Gly from mI if specialized sequences and analysis methods are not available. Quantitative spectral analysis methods may also assist in correctly assigning Gly and mI.

## Linked entities

- **Chemicals:** glycine (PubChem CID 750), myo-inositol (PubChem CID 892)
- **Diseases:** nonketotic hyperglycinemia (MONDO:0011612), hypoxic-ischemic encephalopathy (MONDO:0006663)

## Full-text entities

- **Diseases:** hypoxic-ischemic encephalopathy (MESH:D020925), nonketotic hyperglycinemia (MESH:D020158)
- **Chemicals:** Myo-Inositol (MESH:D007294), Gly (MESH:D005998)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12604077/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12604077/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12604077/full.md

---
Source: https://tomesphere.com/paper/PMC12604077